Acute Response to Tolvaptan in ADPKD: A Window to Predict Long-term Efficacy?

Affiliations

¹ University of Chicago, Chicago, Illinois. Electronic address: breddy@medicine.bsd.uchicago.edu.
² University of Chicago, Chicago, Illinois.

Editorial

Bharathi Reddy et al. Am J Kidney Dis. 2015 Jun.

. 2015 Jun;65(6):811-3.

doi: 10.1053/j.ajkd.2015.03.004.

¹ University of Chicago, Chicago, Illinois. Electronic address: breddy@medicine.bsd.uchicago.edu.
² University of Chicago, Chicago, Illinois.

No abstract available

Comment on

Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function.
Boertien WE, Meijer E, de Jong PE, ter Horst GJ, Renken RJ, van der Jagt EJ, Kappert P, Ouyang J, Engels GE, van Oeveren W, Struck J, Czerwiec FS, Oberdhan D, Krasa HB, Gansevoort RT. Boertien WE, et al. Am J Kidney Dis. 2015 Jun;65(6):833-41. doi: 10.1053/j.ajkd.2014.11.010. Epub 2015 Jan 15. Am J Kidney Dis. 2015. PMID: 25600953